Detalhe da pesquisa
1.
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results.
Nat Med
; 30(5): 1320-1329, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480922
2.
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma.
Cancer Res Commun
; 3(5): 821-829, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377890
3.
PSMA-targeting TGFß-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.
Nat Med
; 28(4): 724-734, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314843